238 related articles for article (PubMed ID: 29085228)
1. Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.
Marques D; Ferreira-Costa LR; Ferreira-Costa LL; Correa RDS; Borges AMP; Ito FR; Ramos CCO; Bortolin RH; Luchessi AD; Ribeiro-Dos-Santos Â; Santos S; Silbiger VN
World J Gastroenterol; 2017 Oct; 23(37):6854-6867. PubMed ID: 29085228
[TBL] [Abstract][Full Text] [Related]
2. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 12 variants in the development of gastric and colorectal cancers.
Cavalcante GC; Amador MA; Ribeiro Dos Santos AM; Carvalho DC; Andrade RB; Pereira EE; Fernandes MR; Costa DF; Santos NP; Assumpção PP; Ribeiro Dos Santos Â; Santos S
World J Gastroenterol; 2017 Dec; 23(48):8533-8543. PubMed ID: 29358861
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation of ErbB4 confers risk of colorectal cancer in a Chinese Han population.
Gao X; Zhang S; Zhu Z
Cancer Biomark; 2014; 14(6):435-9. PubMed ID: 25335735
[TBL] [Abstract][Full Text] [Related]
5. An insertion/deletion polymorphism within the promoter of EGLN2 is associated with susceptibility to colorectal cancer.
Li C; Feng L; Niu L; Teng Li T; Zhang B; Wan H; Zhu Z; Liu H; Wang K; Fu H; Fu W
Int J Biol Markers; 2017 Jul; 32(3):e274-e277. PubMed ID: 28218358
[TBL] [Abstract][Full Text] [Related]
6. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
7. Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
Laaribi AB; Zidi I; Hannachi N; Ben Yahia H; Chaouch H; Bortolotti D; Zidi N; Letaief A; Yacoub S; Boudabous A; Rizzo R; Boukadida J
J Viral Hepat; 2015 Oct; 22(10):835-41. PubMed ID: 25619305
[TBL] [Abstract][Full Text] [Related]
8. 50-bp Ins/Del polymorphism of SOD1 is associated with increased risk of cardiovascular disease.
Eskandari-Nasab E; Kharazi-Nejad E; Nakhaee A; Afzali M; Tabatabaei SP; Tirgar-Fakheri K; Hashemi M
Acta Med Iran; 2014; 52(8):591-5. PubMed ID: 25149881
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
11. Integrating
Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
[TBL] [Abstract][Full Text] [Related]
12. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
[TBL] [Abstract][Full Text] [Related]
13. Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients.
Kallel A; Ben Ali S; Sediri Y; Chabrak S; Elasmi M; Sanhaji H; Souheil O; Haj-Taieb S; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Clin Chem Lab Med; 2008; 46(8):1097-101. PubMed ID: 18590467
[TBL] [Abstract][Full Text] [Related]
14. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
15. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
16. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
17. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 4-bp insertion/deletion polymorphism within the 3'UTR of SGSM3 in bladder cancer using mismatch PCR-RFLP method: A preliminary report.
Hashemi M; Bahari G; Bizhani F; Danesh H; Sarhadi S; Ziaee SAM; Basiri A; Narouie B; Taheri M; Ghavami S
J Cell Biochem; 2018 Aug; 119(8):6566-6574. PubMed ID: 29693742
[TBL] [Abstract][Full Text] [Related]
19. Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer.
Zhu J; Luo JZ; Li CB
Biochem Genet; 2019 Feb; 57(1):147-158. PubMed ID: 30073577
[TBL] [Abstract][Full Text] [Related]
20. Genotyping of -374A/T, -429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients.
Hashemi M; Moazeni-Roodi A; Arbabi F; Fazaeli A; Nasab EE; Taheri M; Kerkhoff C; Ghavami S
Nucleosides Nucleotides Nucleic Acids; 2012 May; 31(5):401-10. PubMed ID: 22497255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
